Effects of high-efficiency postdilution online hemodiafiltration and high-flux hemodialysis on serum phosphorus and cardiac structure and function in patients with end-stage renal disease

International Urology and Nephrology

Volumn 45, Issue 5, 2013, Pages 1373-1378

  Francisco, Rodríguez Castellanos ^a   Aloha, Meave ^a   Ramón, Paniagua Sierra ^b  

^a INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

^b INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

Author keywords

Cardiovascular disease; Hemodiafiltration; Hemodialysis; Phosphorus

Indexed keywords

PHOSPHORUS;

ADULT; ARTICLE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR MAGNETIC RESONANCE; CHRONIC ALLOGRAFT NEPHROPATHY; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; FEMALE; FOLLOW UP; GLOMERULOPATHY; HEART EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEMODIAFILTRATION; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; MORPHOLOGY; NUCLEAR MAGNETIC RESONANCE SCANNER; PHOSPHATE BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; ADULT; FEMALE; HEMODIAFILTRATION; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MYOCARDIUM; ORGAN SIZE; PHOSPHORUS; RENAL DIALYSIS; STROKE VOLUME; VENTRICULAR FUNCTION, LEFT; YOUNG ADULT;

EID: 84887120226     PISSN: 03011623     EISSN: 15732584     Source Type: Journal    
DOI: 10.1007/s11255-012-0324-8     Document Type: Article

References (12)

1. Pozzoni P, Pozzi M, Del Vecchio L, Locatelli F (2004) Epidemiology and prevention of cardiovascular complication in chronic kidney disease patients. Sem Nephrol 24:417-422
2. 4 product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. J Am Soc Nephrol 12:2131-2138
3. Block GA, Port FK (2000) Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: recommendations for a change in management. Am J Kidney Dis 35:1226-1237
4. Minutolo R, Bellizzi V, Cioffi M, Iodice C, Giannattasio P, Andreucci M, Terracciano V, Di Iorio BR, Conte G, De Nicola L (2002) Postdialytic rebound of serum phosphorus: pathogenetic and clinical insights. J Am Soc Nephrol 13:1046-1054
5. Zehnder C, Gutzwiller JP, Renggli K (1999) Hemodiafiltration - a new treatment option for hyperphosphatemia in hemodialysis patients. Clin Nephrol 52:152-159
6. Tuccillo S, Bellizzi V, Catapano F, Di Iorio B, Esposito L et al (2002) Acute and chronic effects of standard hemodialysis and soft hemodiafiltration on interdialytic serum phosphate levels. G Ital Nefrol 19:439-445
7. Lornoy W, De Meester J, Becaus I, Billiouw JM, Van Malderen PA, Van Pottelberge M (2006) Impact of convective flow on phosphorus removal in maintenance hemodialysis patients. J Ren Nutr 16:47-53
8. Penne EL, van der Weerd NC, van der Dorpel MA et al (2010) Short term effects of on-line hemodiafiltration on phosphate control: a result from the randomized controlled convective transport study (CONTRAST). Am J Kidney Dis 55:77-87
9. Davenport A, Gardner C, Delaney M (2010) The effect of dialysis modality on phosphate control: haemodialysis compared to haemodiafiltration - the pan thames renal audi. Nephrol Dial Transpl 25:897-901
10. Saab G, Whooley MA, Schiller NB, Ix JH (2010) Association of serum phosphorus with left ventricular mass in men and women with stable cardiovascular disease: data from the heart and soul study. Am J Kidney Dis 56:496-505
11. Grooteman MP, van den Dorpel MA, Bots ML, Penne EL, van der Weerd NC, Mazairac AH et al (2012) Effect of online hemodiafiltration on all-cause mortality and cardiovascular outcomes. J Am Soc Nephrol 23:1087-1096
12. Vilar E, Fry AC, Wellsted D, Tattersall JE, Greenwood RN, Farrington K (2009) Long-term outcomes in online hemodiafiltration and high-flux hemodialysis: a comparative analysis. Clin J Am Soc Nephrol 4:1944-1953